Johnson Financial Group LLC (Colorado)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
+4,210
New +$242K 0.01% 244
2018
Q1
– Sell
-4,310
Closed -$264K – 69
2017
Q4
$264K Sell
4,310
-69
-2% -$4.32K 0.2% 53
2017
Q3
$279K Buy
4,379
+547
+14% +$31.9K 0.23% 48
2017
Q2
$213K Sell
3,832
-27
-0.7% -$1.47K 0.18% 60
2017
Q1
$210K Buy
+3,859
New +$212K 0.24% 55

Other funds holding BMY

Johnson Financial Group LLC (Colorado)'s BMY Position: Q2 2026 in Review

Johnson Financial Group LLC (Colorado) opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,210 shares worth $243K. The stake represents 0.01% of the portfolio and ranks #244 among its holdings. This is a return to the name: Johnson Financial Group LLC (Colorado) previously reported a position in BMY as recently as Q4 2017.

Johnson Financial Group LLC (Colorado) first reported a position in BMY in Q1 2017 and has held it in 5 quarters since. The position peaked at $279K in Q3 2017. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Johnson Financial Group LLC (Colorado) held 4,210 shares of Bristol-Myers Squibb worth $243K as of Q2 2026.
  • Bristol-Myers Squibb was a new Johnson Financial Group LLC (Colorado) position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Johnson Financial Group LLC (Colorado)'s portfolio in Q2 2026, its #244 holding.
  • Johnson Financial Group LLC (Colorado) first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 5 quarters since.
  • Johnson Financial Group LLC (Colorado)'s Bristol-Myers Squibb position peaked at $279K in Q3 2017.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q2 2026, filed 6 Aug 2026.